Rising Climate And Cyber Risks Will Boost Insurance Demand

Published
01 Jun 25
Updated
08 Aug 25
AnalystHighTarget's Fair Value
US$90.00
35.0% undervalued intrinsic discount
08 Aug
US$58.49
Loading
1Y
-10.6%
7D
1.2%

Author's Valuation

US$90.0

35.0% undervalued intrinsic discount

AnalystHighTarget Fair Value

Key Takeaways

  • Accelerating integration of acquisitions, advanced technology investment, and deep partnerships position Ryan Specialty for outsized growth, sector-leading margins, and sustained earnings gains.
  • The shift of complex risks to specialty markets and rising catastrophe exposure enable rapid market share gains, premium pricing, and long-term revenue durability.
  • Margin pressure and revenue risk are rising due to property pricing declines, heavy investments, higher debt, sector weakness, and unaddressed digital competition threats.

Catalysts

About Ryan Specialty Holdings
    Operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, rest of Europe, India, and Singapore.
What are the underlying business or industry changes driving this perspective?
  • Analyst consensus sees robust organic and M&A-driven growth, but this likely understates Ryan Specialty's scale benefits; with the accelerating integration of acquired businesses, Ryan is poised for compounding top-line and margin expansion, positioning for sustained double-digit organic growth and outperformance on net earnings well beyond current guidance.
  • While analysts broadly agree that expanding solutions and the E&S market share will drive continued growth, the magnitude could be far greater: the intensifying shift of complex and climate-exposed risks from standard to specialty markets may allow Ryan Specialty to gain market share at an unprecedented rate, bolstering revenue and long-term margin expansion as standard carriers retreat.
  • The relentless increase in natural catastrophe frequency and severity is structurally altering demand for specialized risk solutions, enabling Ryan Specialty to win premium placements and secure higher pricing power, which could structurally elevate revenue streams and drive margin durability for years ahead.
  • The company's accelerating investments in technology, AI, and digital distribution are not only operational improvements but could disrupt legacy intermediaries and create step-change net margin efficiencies, supporting sector-leading profitability and earnings-per-share growth.
  • Differentiated by deep, long-standing partnerships with both major carriers and key talent (as seen in the Markel and Nationwide transactions), Ryan Specialty is likely to outpace consolidation peers, using its elite platform as leverage to attract high-quality M&A, command better terms, and unlock long-term compounding EPS growth.

Ryan Specialty Holdings Earnings and Revenue Growth

Ryan Specialty Holdings Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?
  • This narrative explores a more optimistic perspective on Ryan Specialty Holdings compared to the consensus, based on a Fair Value that aligns with the bullish cohort of analysts.
  • The bullish analysts are assuming Ryan Specialty Holdings's revenue will grow by 21.7% annually over the next 3 years.
  • The bullish analysts assume that profit margins will increase from 2.0% today to 21.0% in 3 years time.
  • The bullish analysts expect earnings to reach $1.0 billion (and earnings per share of $3.72) by about August 2028, up from $56.3 million today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the more bullish analyst cohort, the company would need to trade at a PE ratio of 32.5x on those 2028 earnings, down from 134.5x today. This future PE is greater than the current PE for the US Insurance industry at 14.0x.
  • Analysts expect the number of shares outstanding to grow by 5.61% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 6.78%, as per the Simply Wall St company report.

Ryan Specialty Holdings Future Earnings Per Share Growth

Ryan Specialty Holdings Future Earnings Per Share Growth

Risks

What could happen that would invalidate this narrative?
  • There is accelerating property pricing decline, with 20 to 30 percent reductions in recent months and management warning that these headwinds are likely to continue at least through year-end, which directly threatens Ryan Specialty's top-line revenue and margin expansion in the near to medium term.
  • Ryan Specialty is ramping up investments in talent and infrastructure for key initiatives like Ryan Re and Alternative Risk, which are expected to weigh on margins and increase general and administrative expenses, and management noted these are not guaranteed to be margin-accretive until 2026 or later, putting net earnings at risk in the interim.
  • The company's strategy leans heavily on continued robust M&A activity, but increasing debt leverage-currently at 3.5 times net leverage and expected to go higher for accretive deals-raises the risk of higher interest expenses and potential dilution of earnings per share if integration or synergy targets are missed.
  • Declining activity and compressed binding periods in the construction sector, partly due to macroeconomic volatility, elevated interest rates, continued trade war impacts, and delayed project financing, could suppress demand for specialty insurance, directly challenging premium volume and organic growth.
  • The long-term industry trend of insurance disintermediation via digital platforms and increased direct-to-consumer/automated underwriting is not addressed in the company's growth commentary, raising the risk that new entrants and digital-first competitors will erode Ryan Specialty's commission pools and market share, pressuring both revenue and margins over time.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The assumed bullish price target for Ryan Specialty Holdings is $90.0, which is the highest price target estimate amongst analysts. This valuation is based on what can be assumed as the expectations of Ryan Specialty Holdings's future earnings growth, profit margins and other risk factors from analysts on the bullish end of the spectrum.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $90.0, and the most bearish reporting a price target of just $60.0.
  • In order for you to agree with the bullish analysts, you'd need to believe that by 2028, revenues will be $5.0 billion, earnings will come to $1.0 billion, and it would be trading on a PE ratio of 32.5x, assuming you use a discount rate of 6.8%.
  • Given the current share price of $59.55, the bullish analyst price target of $90.0 is 33.8% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

How well do narratives help inform your perspective?

Disclaimer

AnalystHighTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystHighTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystHighTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives